Abstract:Abstract Background As the novel coronavirus triggering COVID-19 has broken out in Wuhan, China and spread rapidly worldwide, it threatens the lives of thousands of people and poses a global threat on the economies of the entire world. However, infection with COVID-19 is currently rare in children. Objective To discuss the latest findings and research focus on the basis of characteristics of children confirmed with COVID-19, and provide an insight into the future treatment and research direction. Methods We searched the terms “COVID-19 OR coronavirus OR SARS-CoV-2” AND “Pediatric OR children” on PubMed, Embase, Cochrane library, NIH, CDC, and CNKI. The authors also reviewed the guidelines published on Chinese CDC and Chinese NHC. Results We included 25 published literature references related to the epidemiology, clinical manifestation, accessary examination, treatment, and prognosis of pediatric patients with COVID-19. Conclusion The numbers of children with COVID-19 pneumonia infection are small, and most of them come from family aggregation. Symptoms are mainly mild or even asymptomatic, which allow children to be a risk factor for transmission. Thus, strict epidemiological history screening is needed for early diagnosis and segregation. This holds especially for infants, who are more susceptible to infection than other age groups in pediatric age, but have most likely subtle and unspecific symptoms. They need to be paid more attention to. CT examination is a necessity for screening the suspected cases, because most of the pediatric patients are mild cases, and plain chest X-ray do not usually show the lesions or the detailed features. Therefore, early chest CT examination combined with pathogenic detection is a recommended clinical diagnosis scheme in children. The risk factors which may suggest severe or critical progress for children are: Fast respiratory rate and/or; lethargy and drowsiness mental state and/or; lactate progressively increasing and/or; imaging showed bilateral or multi lobed infiltration, pleural effusion or rapidly expending of lesions in a short period of time and/or; less than 3 months old or those who underly diseases. For those critical pediatric patients with positive SARS-CoV-2 diagnosis, polypnea may be the most common symptom. For treatment, the elevated PCT seen in children in contrast to adults suggests that the underlying coinfection/secondary infection may be more common in pediatric patients and appropriate antibacterial treatment should be considered. Once cytokine storm is found in these patients, anti-autoimmune or blood-purifying therapy should be given in time. Furthermore, effective isolation measures and appropriate psychological comfort need to be provided timely.

Clinical Experiences in the Management of Critically Ill Patients with COVID-19 in a Designated Children's Hospital in China

Diagnosis, Treatment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children: Experts' Consensus Statement Updated for the Omicron Variant.

Management Experience of a Designated Hospital for Children with Coronavirus Disease 2019.

Clinical Characteristics and Current Treatment of Critically Ill Patients with COVID-19 Outside Wuhan, China: A Multicenter, Retrospective, Observational Study

Clinical Characteristics and Treatment of Critically Ill Patients with COVID-19 in Hebei.

Critically ill children with SARS-COV-2 Omicron infection at a national children medical center, Guangdong, China

Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives

A Mini Review on Current Clinical and Research Findings for Children Suffering from COVID-19

Discussions on the Emergency Medical Procedure of Children′s Hospitals Against COVID-19 Epidemic

[Diagnosis and Treatment Recommendation for Pediatric Coronavirus Disease-19].

Clinical Characteristics of Pediatric Cases Infected with the SARS-CoV-2 Omicron Variant in a Tertiary Children’s Medical Center in Shanghai, China

Take Precautions Beforehand: Calling for Clinical Trials of Pediatric Drugs for Treating Coronavirus Disease 2019.

Epidemiological and clinical features of pediatric COVID-19

The clinical and immunological features of pediatric COVID-19 patients in China

Clinical characteristics and factors associated with severe COVID-19 in hospitalized children during the SARS-CoV-2 Omicron pandemic in Taiwan

Epidemiological characteristics and clinical manifestations of pediatric patients with COVID-19 in China: A multicenter retrospective study

A systematic review and meta‐analysis of children with coronavirus disease 2019 (COVID‐19)

Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China

Accumulated Clinical Experiences from Successful Treatment of 1377 Severe and Critically Ill COVID-19 Cases

Experience on prevention and control management of the pediatric emergency department during the pandemic of Omicron variant of novel coronavirus in Shanghai in 2022

Infection with the SARS-CoV-2 Omicron variant in children with congenital heart disease: A case series study during Shanghai epidemic